REC-102 An investigational oral ENPP1 inhibitor undergoing candidate profiling for hypophosphatasia and impaired bone mineralization.
Visit productCosigns Received
Be the first Cosign
Put your name behind REC-102.
Add it to your Products I use list and share why you use it.